Kieran Reynolds talks to Arron Jones, Lead Hepatology Pharmacist about metabolic dysfunction associated steatotic liver disease (MASLD). Discussion includes what MASLD/MASH stands for, prevalence, diagnosis, treatment; including advice to give to patients accessing GLP-1 RAs online, and emerging therapies.

Arron Jones - Lead Hepatology Pharmacist, Bart’s Health Trust

Kieran Reynolds - Advanced Specialist Pharmacist (Medicines Governance), SPS

Useful links:

The British Liver Trust’s information on MASLD, NAFLD and fatty liver disease

https://britishlivertrust.org.uk/information-and-support/liver-conditions/masld-nafld-and-fatty-liver-disease/

The NHS Eatwell Guide

https://www.nhs.uk/live-well/eat-well/food-guidelines-and-food-labels/the-eatwell-guide/

The South Asian Eatwell Guide

https://mynutriweb.com/the-south-asian-eatwell-guide/

SPS article on using statins in liver impairment

https://www.sps.nhs.uk/articles/using-statins-in-liver-impairment/

The General Pharmaceutical Council’s FAQs on weight loss medications (including a guide for patients on how to keep safe when getting medicines or treatment online: scroll to bottom of page to access)

https://www.pharmacyregulation.org/patients-and-public/standards-you-can-expect-using-pharmacy-services/weight-loss-medications-faq